**Author Information** An event is serious (based on the ICH definition) when the patient outcome is:\* death\* life-threatening\* hospitalisation\* disability\* congenital anomaly\* other medically important event

In a case series of 5 patients enrolled from 24 January 2020 to 29 January 2020, an 80-year-old man was described, who exhibited lack of efficacy during treatment with meropenem, tigecycline, colistin and levofloxacin for *Acinetobacter baumanii*(*A. baumanii*) infection, and voriconazole and isavuconazole for *Aspergillus flavus*(*A. flavus*) infection \[*dosages and routes not stated*\].

The man, who had undergone a thyroid cancer removal in 2010, was admitted with a fever and diarrhoea on 22 January 2020. He was diagnosed with COVID-19 infection on 28 January 2020 in France. He was then shifted to the ICU due to acute respiratory failure, and was treated with remdesivir. His tracheal aspirates culture revealed *A. baumannii*and *A. flavus*pathogens. Hence, he was treated with meropenem, colistin \[colimycin\], tigecycline and meropenem, followed by meropenem and levofloxacin for *A. baumanii*infection. The *A. flavus*infection was treated initially with voriconazole, which was later changed to isavuconazole. On 30 January 2020, the treatment with remdesivir was stopped as he required renal replacement therapy. On 31 January 2020, a CT scan revealed bilateral pleuropneumopathy comprising including alveolar condensations, pleural effusion, pulmonary cysts and ground-glass opacities. Subsequently, he developed multiple organ failure, acute kidney injury, liver failure and sepsis-like shock as complications of the infection. Due to the favourable risk-benefit assessment, severity of the disease and persistent viral detection, he was re-initiated on remdesivir on 5 February 2020. Despite the appropriate treatment for infections, his multiple organ failure and the infections persisted, which was indicative of lack of efficacy. On day 24 of the illness (14 February 2020), he died \[*immediate cause of death not stated*\].
